Abstract:3D in vitro engineered heart tissue (EHT) models recapitulate aspects of native cardiac physiology but are often limited by scalability, cost, and reproducibility. Here, we report a simple, one-step method for rapid fabrication of molds using digital light processing (DLP)-based 3D printing that support the formation of EHTs by human induced pluripotent stem cell derived cardiomyocytes (iPSC-CMs) with high reproducibility (>95% efficiency) and varied designs (e.g., length, aspect ratio). Compared to 2D iPSC-CMs, 3D EHTs display enhanced maturity, including increased expression of B-oxidation genes, higher concentrations of sarcomeric myosins, improved sarcomere density and alignment, and enrichment of cardiac pathways (e.g., upregulation of sodium channels, action potentials, contraction). The technology is applied to model pathological cardiac hypertrophy in vitro, using either (i) acute adrenergic agonism or (ii) chronic culture within stiff hydrogel molds. Treated EHTs exhibit increased levels of pathology-associated gene expression and activation of signaling cascades involved in pathological remodeling compared to untreated controls or treated 2D iPSC-CMs. Thus, our method results in robust yet simpler, cheaper, and faster EHTs to study cardiac disease.

What problem does this paper attempt to address?

This paper aims to solve several key problems in current in - vitro research on heart disease models, specifically including: 1. **Scalability**: Existing cardiac tissue engineering methods are often limited by low yield and high cost, making it difficult to achieve large - scale production, which restricts their application in drug screening and disease modeling. 2. **Cost**: Traditional cardiac tissue engineering techniques are not only costly but also require complex equipment and professional operating skills, all of which increase the difficulty of popularizing the technology. 3. **Reproducibility**: When manufacturing cardiac tissue, existing methods result in large fluctuations in tissue quality and function due to complex processes and inconsistent operating conditions, affecting the reliability and repeatability of experimental results. 4. **Physiological relevance**: Traditional two - dimensional cell cultures or simple three - dimensional models cannot fully simulate the complex structure and functional characteristics of cardiac tissue, especially in terms of cell - cell interactions and cell - extracellular matrix (ECM) interactions, which are crucial for studying heart diseases. To solve the above problems, this paper proposes a new method based on digital light processing (DLP) 3D printing technology for rapidly and efficiently manufacturing human - engineered heart tissue (EHT). This method can achieve the following improvements: - **Rapid manufacturing**: Through DLP 3D printing technology, the production of molds can be completed within a few minutes, greatly improving production efficiency. - **Low cost**: The use of commercial materials and relatively simple equipment reduces manufacturing costs, making the technology easier to promote. - **High reproducibility**: By precisely controlling printing parameters, it is ensured that each batch of EHT produced has a high degree of consistency and reliability. - **Design flexibility**: The design of the mold can be adjusted by simply modifying the computer - aided design (CAD) file to meet different experimental requirements. - **Physiological maturity**: Compared with traditional two - dimensional cultures, DLP - printed EHT exhibits higher metabolic maturity and better contractile function, closer to real cardiac tissue. In summary, by developing a new DLP 3D printing technology, this paper solves the deficiencies of existing cardiac tissue engineering methods in terms of scalability, cost, reproducibility, and physiological relevance, providing a more effective tool for in - vitro research on heart diseases.

Digital Light Processing 3D Printing enables High Throughput Fabrication of Human Engineered Heart Tissues for Disease Modeling